Clinical trial
Safety and Efficacy of the SyMap Bronchial Ablation System for Treatment of Severe Asthma: A Prospective, Multicenter, Randomized Controlled Clinical Trial (Bronchial Ablation for Treatment of Asthma (BATA) Trial)
NCT03765307 is registered in ClinicalTrials.gov with SyMap Medical (Suzhou), Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of the SyMap Bronchial Ablation System for Treatment of Severe Asthma: A Prospective, Multicenter, Randomized Controlled Clinical Trial (Bronchial Ablation for Treatment of Asthma (BATA) Trial)
- Lead sponsor
- SyMap Medical (Suzhou), Ltd.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 18, 2019
- Completion date
- December 31, 2028
- Enrollment
- 160 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.